Oncolyze Announces FDA Orphan Drug Designation for OM-301 for the Treatment of Multiple Myeloma
Oncolyze, which already holds an Orphan Drug Designation for its lead drug candidate OM-301 in treating acute myeloid leukemia (AML), is pleased to announce that...
IQ-AI Announces Orphan Drug Designation Status
MILWAUKEE, WI / ACCESSWIRE / February 28, 2023 / IQ-AI Limited, (OTCQB:IQAIF)(LSE:IQAI), and its US-based subsidiary, Imaging Biometrics, LLC (Milwaukee, WI) is pleased to announce...